Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on June 23, 2003

Circulation. 2003
Published online before print June 23, 2003, doi: 10.1161/01.CIR.0000079100.38176.83
A more recent version of this article appeared on July 8, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/1/97    most recent
01.CIR.0000079100.38176.83v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, E.
Right arrow Articles by Villanueva, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, E.
Right arrow Articles by Villanueva, F. S.
Related Collections
Right arrow Pacemaker
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Ischemic biology - basic studies
Right arrow Peripheral vascular disease

Submitted on January 13, 2003
Revised on March 14, 2003
Accepted on March 26, 2003

Targeted In Vivo Labeling of Receptors for Vascular Endothelial Growth Factor. Approach to Identification of Ischemic Tissue

Erxiong Lu MD, William R. Wagner PhD, Ute Schellenberger PhD, Judith A. Abraham PhD, Alexander L. Klibanov PhD, Steven R. Woulfe PhD, Melissa M. Csikari BS, David Fischer BS, George F. Schreiner MD, Gary H. Brandenburger PhD, and Flordeliza S. Villanueva MD*

From the University of Pittsburgh (E.L., W.R.W., M.M.C., D.F., F.S.V.), Cardiovascular Institute and Department of Bioengineering, Pittsburgh, Pa; Scios Inc (U.S., J.A.A., G.F.S.), Sunnyvale, Calif; and Mallinckrodt Inc (A.L.K., S.R.W., G.H.B.), St Louis, Mo.

* To whom correspondence should be addressed. E-mail: villanuevafs{at}msx.upmc.edu.

Background--A method for identifying tissue experiencing hypoxic stress due to atherosclerotic vascular disease would be clinically useful. Vascular endothelial growth factor-121 (VEGF121) is an angiogenic protein secreted in response to hypoxia that binds to VEGF receptors overexpressed by ischemic microvasculature. We tested the hypothesis that VEGF receptors could serve as markers for ischemic tissue and hence provide a target for imaging such tissue with radiolabeled human VEGF121.

Methods and Results--A rabbit model of unilateral hindlimb ischemia was created by femoral artery excision (n=14). Control rabbits (n=5) underwent identical surgery without femoral excision. On postoperative day 10, rabbits were intravenously administered 100 µCi of 111In-labeled recombinant human VEGF121, and biodistribution studies and planar imaging were conducted at 3, 24, and 48 hours. On postmortem gamma counting, there was greater accumulation of 111In-labeled VEGF121 in ischemic than in control tissue (P<0.02). Differential uptake of isotope by ischemic muscle was not seen in rabbits injected with 125I-labeled human serum albumin (n=6). Radioactivity imaged in hindlimb regions of interest was significantly higher in ischemic muscle than in sham-operated and contralateral nonoperated hindlimb at 3 hours (P<0.02). Immunohistochemical staining confirmed upregulation of VEGF receptors in ischemic skeletal muscle.

Conclusions--Identification of the ischemic state via targeted radiolabeling of hypoxia-induced angiogenic receptors is possible. This approach could be useful for monitoring the efficacy of revascularization strategies such as therapeutic angiogenesis.


Key words: angiogenesis • hypoxia • imaging • isotopes • receptors




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
T. E. Peterson and H. C. Manning
Molecular Imaging: 18F-FDG PET and a Whole Lot More
J. Nucl. Med. Technol., September 1, 2009; 37(3): 151 - 161.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. W. Dobrucki, D. P. Dione, L. Kalinowski, D. Dione, M. Mendizabal, J. Yu, X. Papademetris, W. C. Sessa, and A. J. Sinusas
Serial Noninvasive Targeted Imaging of Peripheral Angiogenesis: Validation and Application of a Semiautomated Quantitative Approach
J. Nucl. Med., August 1, 2009; 50(8): 1356 - 1363.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70.
[Full Text] [PDF]


Home page
JNMHome page
B. L. Franc, P. D. Acton, C. Mari, and B. H. Hasegawa
Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation
J. Nucl. Med., October 1, 2008; 49(10): 1651 - 1663.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
T. H. Marwick and M. Schwaiger
The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools
Circ Cardiovasc Imaging, July 1, 2008; 1(1): 58 - 69.
[Full Text] [PDF]


Home page
JNMHome page
M. Rodriguez-Porcel, W. Cai, O. Gheysens, J. K. Willmann, K. Chen, H. Wang, I. Y. Chen, L. He, J. C. Wu, Z.-b. Li, et al.
Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET
J. Nucl. Med., April 1, 2008; 49(4): 667 - 673.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. K. Willmann, K. Chen, H. Wang, R. Paulmurugan, M. Rollins, W. Cai, D. S. Wang, I. Y. Chen, O. Gheysens, M. Rodriguez-Porcel, et al.
Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography
Circulation, February 19, 2008; 117(7): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Cai, K. Chen, K. A. Mohamedali, Q. Cao, S. S. Gambhir, M. G. Rosenblum, and X. Chen
PET of Vascular Endothelial Growth Factor Receptor Expression
J. Nucl. Med., December 1, 2006; 47(12): 2048 - 2056.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
W. Cai, J. Rao, S. S. Gambhir, and X. Chen
How molecular imaging is speeding up antiangiogenic drug development.
Mol. Cancer Ther., November 1, 2006; 5(11): 2624 - 2633.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Chan, J. Sandhu, A. Guha, D. A. Scollard, J. Wang, P. Chen, K. Bai, L. Lee, and R. M. Reilly
A Human Transferrin-Vascular Endothelial Growth Factor (hnTf-VEGF) Fusion Protein Containing an Integrated Binding Site for 111In for Imaging Tumor Angiogenesis
J. Nucl. Med., October 1, 2005; 46(10): 1745 - 1752.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. S. Villanueva
Molecular Images of Neovascularization: Art for Art's Sake or Form With a Function?
Circulation, June 21, 2005; 111(24): 3188 - 3191.
[Full Text] [PDF]


Home page
CirculationHome page
M. Simons
Angiogenesis: Where Do We Stand Now?
Circulation, March 29, 2005; 111(12): 1556 - 1566.
[Full Text] [PDF]


Home page
JNMHome page
S. Maschauer, O. Prante, M. Hoffmann, J. T. Deichen, and T. Kuwert
Characterization of 18F-FDG Uptake in Human Endothelial Cells In Vitro
J. Nucl. Med., March 1, 2004; 45(3): 455 - 460.
[Abstract] [Full Text]